JO3123B1 - Quinoline derivative-containing pharmaceutical composition - Google Patents

Quinoline derivative-containing pharmaceutical composition

Info

Publication number
JO3123B1
JO3123B1 JOP/2011/0055A JOP20110055A JO3123B1 JO 3123 B1 JO3123 B1 JO 3123B1 JO P20110055 A JOP20110055 A JO P20110055A JO 3123 B1 JO3123 B1 JO 3123B1
Authority
JO
Jordan
Prior art keywords
pharmaceutical composition
containing pharmaceutical
quinoline derivative
hydrogen atom
group
Prior art date
Application number
JOP/2011/0055A
Other languages
Arabic (ar)
Inventor
Bando Masashi
Original Assignee
Eisai R&D Man Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eisai R&D Man Co Ltd filed Critical Eisai R&D Man Co Ltd
Priority to JOP/2011/0055A priority Critical patent/JO3123B1/en
Application granted granted Critical
Publication of JO3123B1 publication Critical patent/JO3123B1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

A pharmaceutical composition comprising a compound represented by the formula (I) or pharmaceutically acceptable salt thereof or solvate thereof; and a basic substance is excellent in dissolution, is stable even after a long term storage, and is useful as a preventive or therapeutic agent against a tumor: wherein, R1 is a hydrogen atom, a C1-6 alkyl group or a C3-8 cycloalkyl group; and R2 is a hydrogen atom or a methoxy group.
JOP/2011/0055A 2011-02-16 2011-02-16 Quinoline derivative-containing pharmaceutical composition JO3123B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JOP/2011/0055A JO3123B1 (en) 2011-02-16 2011-02-16 Quinoline derivative-containing pharmaceutical composition

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JOP/2011/0055A JO3123B1 (en) 2011-02-16 2011-02-16 Quinoline derivative-containing pharmaceutical composition

Publications (1)

Publication Number Publication Date
JO3123B1 true JO3123B1 (en) 2017-09-20

Family

ID=63684620

Family Applications (1)

Application Number Title Priority Date Filing Date
JOP/2011/0055A JO3123B1 (en) 2011-02-16 2011-02-16 Quinoline derivative-containing pharmaceutical composition

Country Status (1)

Country Link
JO (1) JO3123B1 (en)

Similar Documents

Publication Publication Date Title
MY162940A (en) Quinoline derivative-containing pharmaceutical composition
PH12017501192B1 (en) Certain amino-pyridazines, compositions thereof, and methods of their use
MX2016006336A (en) Pyrazolopyrimidine compounds.
MY163498A (en) Certain amino-pyrimidines, compositions thereof, and methods for their use
CA2875877C (en) Syk inhibitors
MX2021008356A (en) Jak2 and alk2 inhibitors and methods for their use.
MD20140084A2 (en) New indolizine derivatives, method for preparing same and pharmaceutical compositions containing same
MX2014001595A (en) Indazole compounds, compositions and methods of use.
IN2014MN02598A (en)
MX2013003019A (en) Azabenzothiazole compounds, compositions and methods of use.
IN2012DN03337A (en)
IN2012DN00765A (en)
WO2013106761A3 (en) Antimicrobial agents
WO2013177534A3 (en) New salicylic acid derivatives, pharmaceutically acceptable salt thereof, composition thereof and method of use thereof
PH12015502429A1 (en) Dicarboxylic acid compound
MY161749A (en) Compound, certain novel forms thereof, pharmaceutical compositions thereof and methods for preparation and use
MX2011011716A (en) Novel isoquinoline derivatives.
MX2013002694A (en) Tetrahydroquinoline derivatives used as ampk activators.
MX345264B (en) Azole derivative.
MX2015010434A (en) Substituted bisphenyl butanoic acid derivatives as nep inhibitors with improved in vivo efficacy.
MX355654B (en) Paroxetine derivative.
JO3123B1 (en) Quinoline derivative-containing pharmaceutical composition
RS53032B (en) Dihydro-oxazolobenzodiazepinone derivatives, processes for their preparation and pharmaceutical compositions comprising these compounds
TN2015000058A1 (en) Salts of benzothiazolone compound as beta-2-adrenoceptor agonist
NZ630795A (en) Crystalline form of vsn16